UNH Share Price – Current Levels and Key Metrics

UnitedHealth Group stock trades between $270 and $274 on the New York Stock Exchange, reflecting a period of significant volatility for the healthcare giant. Recent sessions saw the ticker settle at $273.38, marking a modest 0.35% advance over 24 hours amid fluctuating market conditions. The company’s market capitalization hovers near $247 billion to $280 billion, placing it among the most heavily weighted components in major indices.

Investors monitoring NYSE:UNH face a complex landscape of divergent data across platforms, with real-time quotes varying by timing and exchange reporting delays. The stock has demonstrated remarkable range over the past year, swinging from depths near $234 to peaks approaching $622, creating both opportunity and uncertainty for portfolio managers.

What is the Current UNH Share Price?

• Recent trades cluster around $273, showing consolidation after a 40% recovery from July 2025 lows
• Daily trading volume remains below the 8.6–9 million share average, indicating cautious participation
• Platform discrepancies persist between Morningstar data and alternative feeds
• Market capitalization calculations vary by $33 billion depending on share count and price timing
• Current levels represent a 60% decline from 52-week highs recorded earlier in the year
• Price action shows resilience above the $270 support level in recent sessions

Key Financial Metrics for UNH Stock

Market Capitalization and Valuation Measures

UnitedHealth Group commands a market capitalization ranging from approximately $247 billion to $280 billion, reflecting the discrepancy between different data providers’ share counts and price snapshots. The stock trades at a price-to-sales ratio between 0.55x and 0.6x, suggesting market participants value each dollar of revenue at roughly half its nominal worth. Investing.com metrics indicate a normalized P/E ratio spanning 11.1 to 16.59, positioning the shares at a discount compared to broader healthcare sector multiples.

Dividend and Earnings Indicators

The stock delivers a dividend yield between 2.79% and 2.8%, offering income-oriented investors a defensive component amid price volatility. Earnings per share metrics support the relatively modest P/E multiples, though exact EPS figures vary across reporting agencies. The PEG ratio of 0.21x exceeds sector averages, signaling potential undervaluation relative to earnings growth trajectories.

UNH Stock Performance and History

Extreme 52-Week Volatility

Over the past twelve months, NYSE:UNH has traversed a staggering range from $234.60 to $622.83, representing one of the widest spreads among large-cap healthcare constituents. This 165% potential variance reflects sustained selling pressure followed by intermittent recovery rallies. Trading data shows the equity has surrendered approximately 60% from its annual peak while mounting a 40% rebound from July 2025 nadirs.

Volume and Liquidity Patterns

Recent trading sessions generated volume between 2 million and 8.18 million shares, consistently trailing the 8.6–9 million average. This diminished participation suggests institutional hesitation despite the discounted valuation levels. Options markets reflect bearish sentiment with 128,000 contracts changing hands, indicating hedging activity against further declines.

Is UNH Stock a Good Buy? Analyst Views

Price Targets and Rating Divergence

Sell-side analysts maintain an average price target of $446, implying upside potential between 22.7% and 63% from current trading levels near $274. However, dispersion remains extreme, with forecasts ranging from HSBC’s $270 Reduce rating to optimistic projections near $600. Raymond James recently upgraded shares to Outperform with a $330 target, citing artificial intelligence initiatives driving margin expansion.

Institutional Positioning Changes

Large-cap healthcare funds continue to rebalance positions amid the volatility, with some value-oriented managers accumulating shares at current discounted multiples while growth-focused funds reduce exposure pending clearer earnings trajectory signals.